This bill would restrict access to mifepristone, a medication used for medical abortion, by requiring the FDA to revert to stricter safety protocols from 2011 and banning its importation into the United States. Within 90 days of enactment, the Secretary of Health and Human Services must withdraw the current approval process for mifepristone and replace it with the earlier, more restrictive risk evaluation and mitigation strategy, which previously limited how the drug could be distributed and used. The bill also creates a private right of action allowing individuals who claim to have suffered harm from mifepristone obtained through telehealth providers or mail to sue those providers for compensatory damages, punitive damages, and attorney's fees. Additionally, the legislation explicitly prohibits importing mifepristone into the United States through any means, including mail delivery to individuals. The bill contains no specific funding provisions and establishes a 90-day timeline for implementation of most provisions.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.